knowledge -WSS

knowledge

author：Wikipedia 2025-08-28 06:24:32 - browse：9137

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Study: Hearing aids may slow cognitive decline in those at risk

Wikipedia

WSS

Readout Newsletter: Bristol, Sangamo, Gilead, and more

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Male and female sex labels in research insufficient, scientists say

Ebola: Gilead Sciences antiviral shows promise as new treatment

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

How many hemophilia patients actually want gene therapy?

focus

knowledge

leisure time

The cancer drug shortage isn’t new — and neither are the solutions

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Tori Bowie and the unacceptable rates of Black maternal death

Biden administration sends mixed signals on US soldier who crossed into North Korea

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

First U.S. drug developed to treat liver disease MASH is approved

After affirmative action ruling, medical educators look to 'holistic review'

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Trump demands the U.S. pay no more for drugs than other countries … again

A Theranos scientist

hotspot

What we know about the American soldier detained in North Korea

John Green on his newest strategy for fighting tuberculosis

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Steward Health Care Massachusetts hospitals face fiscal disaster

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

HHS secretary Becerra pressed on Change HealthCare cyberattack

Wikipedia

hotspot

leisure time

Wikipedia